Key result
DDR1 inhibition improves cardiac function and reduces fibrosis in hypertensive rats by decreasing ROCK1-driven signaling.
Why the study?
Hypertension induces fibrotic myocardial remodeling progressing to heart failure, but the specific mechanistic role of DDR1 in hypertension-induced myocardial fibrosis remained to be investigated.
Does DDR1 inhibition reduce myocardial fibrosis and improve cardiac function in a rat model of hypertension-induced myocardial fibrosis?
Does DDR1 inhibition reduce myocardial fibrosis and improve cardiac function in a rat model of hypertension-induced myocardial fibrosis?
DDR1 promotes myocardial fibrosis by stabilizing SP1 and upregulating ROCK1, highlighting DDR1 as a potential therapeutic target for hypertension-induced myocardial fibrosis.
Should not yet change clinical practice; leaves open DDR1 inhibition as target for hypertensive myocardial fibrosis.
Background Myocardial fibrosis (MF) is a common pathological manifestation of end‐stage cardiovascular diseases such as hypertension. Hypertension increases cardiac afterload and induces fibrotic myocardial remodeling, ultimately progressing to heart failure. DDR1 (discoidin domain receptor 1), a collagen‐activated receptor, plays a pivotal role in multiorgan fibrosis progression. However, its specific mechanistic role in hypertension‐induced MF remains to be investigated. Methods A pressure overload–induced MF model was established in male spontaneously hypertensive rats, and cardiac fibroblasts were stimulated with angiotensin II to induce a fibrotic phenotype. Cardiac function and fibrosis were assessed through echocardiography combined with histological/cellular staining. Western blotting, quantitative reverse transcription polymerase chain reaction, immunoprecipitation, and ubiquitination assays were used to investigate molecular mechanisms. Results Results demonstrated upregulated DDR1 expression in both activated cardiac fibroblasts and fibrotic hearts of spontaneously hypertensive rats. DDR1 inhibition improved cardiac structure and function in spontaneously hypertensive rats, while reducing the fibrotic phenotype of cardiac fibroblasts and attenuating MF progression. Mechanistically, DDR1 enhances direct interaction with SP1 (specificity protein 1), suppressing its ubiquitination and degradation. SP1 binds to the ROCK1 (rho‐associated protein kinase 1) gene promoter to strengthen transcriptional regulation, thereby upregulating ROCK1 and downstream profibrotic signaling pathways. Conclusions In summary, this study demonstrates that DDR1 is a pivotal driver of MF progression, establishing both a theoretical foundation and an experimental basis for DDR1‐targeted therapy in MF.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question. DDR1 inhibition improved cardiac function and reduced myocardial fibrosis by preventing SP1 ubiquitination, thereby decreasing ROCK1-driven profibrotic signaling in hypertensive rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: